prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Pathology #: Med. Record. No. Date of Birth: F. Date Received: Submitted by: Report also to. DIAGNOSIS: A. Right axillary sentinel node: Lymph node with metastatic.mammary carcinoma (5 mm focus), with extranodal. extension (less than 2 mm). B. Right axillary sentinel nodes: Metastatic mammary carcinoma (5 mm focus), without extracapsular extension involving. 1 of 2 lymph nodes. C. Left breast tissue. Benign breast tissue with fibrocystic changes. D. SPECIMEN. Laterality: Right breast. Specimen(s). Modified radical mastectomy. TUMOR. Histologic type: Invasive lobular carcinoma (two separate lesions). Histologic grade: Grade 1. Tumor grade (Nottingham combined) based on the following: Tubule formation score: 3. Nuclear pleomorphism score: 1. Mitotic count score: 1. Total score (range of 3-9): 5. Tumor size (greatest dimension): 7cm. Tumor site (quadrant): Upper. outer. Tumor site (add'l descriptors): O'clock orientation. Larger lesion - upper outer (9:00 - 11:00) 5-6 cm. from nipple; and smaller lesion - upper inner (2:00). 7-8 cm from nipple. Peritumoral intralymphatic tumor emboli: Absent. Dermal lymphatic involvement: Absent. Status of skin/nipple: Not involved. Coexistent DCIS: Absent. Microcalcifications: Absent. Additional findings: None. MARGINS. Regarding invasive carcinoma: Margin(s) positive: Posterior margin - 2mm linear extent. Margin(s) negative: Superior: > 1 cm. Medial: > 1cm. Inferior: > 1 cm. Lateral: > 1 cm. ANCILLARY STUDIES. IHC for ER and PR: Performed on a prior sample. See report: HER2 amplification by FISH: Performed on a prior sample. See report: REGIONAL LYMPH NODES. Positive for metastatic carcinoma (at least one focus > 0.2mm in size). Number of nodes positive: 2. Total number of nodes evaluated: 26. Size of largest metastatic focus: 5mm. Extranodal extension: Present. (tumor extends 2 mm or less beyond node capsule). Comment: The two positive lymph nodes are the sentinel lymph nodes from Part A (one sentinel. node) and Part B (1 of 2 sentinel nodes). STAGING (AJCC). Primary Tumor: pT3. Lymph Nodes: pN1a. Distant Metastasis: Not applicable. CLINICAL INFORMATION: Right breast multicentric cancer, ER/PR done previous biopsy. SPECIMEN(S) RECEIVED: A. Right axillary sentinel node. B. Right axiliary sentinel nodes. C. Left breast tissue. D. Right modified radial mastectomy with multicentric cancer. GROSS DESCRIPTION: A. Received fresh is a 2.3 x 2 x 1.5 cm fragment of golden yellow fibroadipose tissue containing one rubbery. partially fat-replaced 1.1 x 1 x 0.4 cm lymph node. The node is bisected and submitted for frozen section in A1. FROZEN SECTION DIAGNOSIS: Lymph node, positive for metastatic breast carcinoma. B. Received fresh is a3x2x15 cm fragment of golden yellow fibroadipose tissue. Dissection reveals two. rubbery, partially fat-replaced nodes, 0.6 x 0.6 x 0.4 cm and 1.1 x 0.9 x 0.5 cm. Both nodes are bisected and. submitted for permanent section in B1 and B2. C. Received fresh are two fragments of lobular golden yellow fibroadipose tissue along with attached and. unattached smooth, unremarkable tan-red skin weighing 256 grams in aggregate and measuring from 5 x 3.4 x 2.2. cm to 16 x 11 x 3.5 cm. Sectioning reveals a cut surface consistent of lobular yellow adipose tissue interspersed. with fibrous pink-white breast parenchyma. Representative tissue is submitted in C1 - C2. D. Fixed in formalin for approximately 33 hours is a 1,215 gram modified radical mastectomy with the breast. proper measuring 20 cm from medial to lateral x 19.5 cm from superior to inferior x 7 cm from anterior to posterior. Dissection of the 11 x 6 x 4 cm axillary tail reveals several rubbery tan-red lymph nodes, 0,3 to 2.3 x 1.5 x 1.1 cm. There is an 18 x 9 cm ellipse of tan-red skin on the anterior surface with a superomedial placed nipple. The. superior margin is inked black, inferior blue. medial green, lateral yellow and posterior red. The specimen is. serially sectioned from medial to lateral into 17 slices measuring from 1 to 1.3 cm. In the upper outer quadrant. of. the breast is a large firm, multinodular, ill-defined 7 x 5 x 3.8 cm pink-gray mass which extends from the 9 to 11. o'clock position, 5-6 cm away from the nipple. This large, multinodular lesion appears grossly to come within 0.5. cm of the posterior margin, 1.5 cm of the superior margin and greater than 2 cm away from all remaining margins. in the upper inner quadrant of the breast at approximately the 2 o'clock position, 7-8 cm away from the nipple is a. smaller, firm, ill-defined 0.9 x 0.9 x 0.8 cm pink-gray mass located 1 cm away from the superior margin and greater. than 2 cm from all remaining margins. This mass appears grossly to be located 3.5 cm away from the larger lesion. The rest of the specimen consists of lobular yellow adipose tissue interspersed with fibrous pink-white breast. parenchyma. A photograph of slices 4 through 14 is taken to illustrate both lesions and their relationship to the. inked margins. Sections submitted are indicated on the photograph and are sublabeled D10-D25. Sections to. include the mass at 2 o'clock are in D10 and D11, and the mass at the 1 to 3 o'clock position is in D14, D15, 017,. D20, D21, D22, D23, D24 and D25. The nipple is in D13, and an additional section of medial breast is in D8 and. lateral breast in D9. The lymph nodes are submitted as follows: D1-D2 - one node trisected: D3 - one node. bisected; D4-D7 - intact lymph nodes; D8 - medial breast tissue; D9 - lateral breast tissue. Slides were microscopically examined by the pathologist. Immunohistochemistry Results. Formalin-fixed paraffin-embedded tissue is utilized. Tissue sections are incubated with the following antibodies. Positive and. negative controls stain appropriately. Complete procedural methodology is available upon request. Results indicated below: Material: Block D22. Marker For: Comment. e-Cadherin. Negative. The immunohistochemical findings support the diagnosis of invasive lobular carcinoma. Note. charactentics of all immunohistochemical stains cited in this report were determined by the Department of Pathology at. as part of an ongoing quality assurance program and in compliance with federally mandated regulations. drawn from the Cilinical Laboratory Amendments of 1988 (CLIA '88) Some of these tests may rely on the use of tanalyte specific. reagents and have not been cleared or approved by the U.S Food and Drug Administration The FDA has determined that such clearance. or. approval is not necessary. Nevertheless, federal rules concerning the medical use of analyte specific reagents require that the following. disclaimer be attached to this report. These tests are used for clinical numpses and should not be regarded as investigational or for research. The immunohistochemistry laboratory at. lepartment of Pathology is certified by the Centers for Medicare. and Medicaid Services (formerly HCFA) as a high complexity laboratory under CLIA 88. Evaluation performed bu. diectronically signed.

expanded version (tokens=2221) : 
 Histological classification:
- Right axillary sentinel node: Lymph node with metastatic mammary carcinoma (5 mm focus), with extranodal extension (less than 2 mm).
- Right axillary sentinel nodes: Metastatic mammary carcinoma (5 mm focus), without extracapsular extension involving 1 of 2 lymph nodes.
- Left breast tissue: Benign breast tissue with fibrocystic changes.
- Right breast tissue: Invasive lobular carcinoma (two separate lesions).

Subtypes: No subtypes mentioned.

Necrosis: No necrosis mentioned.

Tumor-infiltrating lymphocytes: No mention of tumor-infiltrating lymphocytes.

Histological grade: Grade 1 (Nottingham combined).

Nuclear grade: Score of 1.

Lymphovascular invasion: Absent.

Calcification: Microcalcifications absent.

Receptor status: ER and PR tested previously, results not provided in this report. HER2 amplification tested previously, results not provided in this report.

Ancillary testing results: 
- IHC for e-Cadherin: Negative.
- Sentinel lymph nodes evaluated: 2 positive for metastatic carcinoma, with a focus >0.2 mm in size. 
- AJCC Staging: Primary Tumor pT3; Lymph Nodes pN1a; Distant Metastasis Not applicable.

Other findings: 
- Margin(s) positive: Posterior margin - 2mm linear extent. 
-

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=2389) : 
 A 7cm invasive lobular carcinoma in the upper outer quadrant of the right breast was found in a modified radical mastectomy specimen. The tumor is grade 1 with nuclear score of 1, absent necrosis, lymphovascular invasion and calcification. Posterior margin was positive for tumor (2mm extent). Two sentinel nodes were positive for metastatic carcinoma with extranodal extension of <2mm. HER2 amplification not available. Ancillary testing for e-Cadherin negative. AJCC staging: Primary Tumor pT3; Lymph Nodes pN1a.

